L’Oréal claims that its new skincare device can identify the ingredients that benefit you the most.
Its goal is to personalize skincare by informing you about how your skin is aging.
L’Oréal is introducing a new beauty device called Cell BioPrint, aimed at simplifying skin care. During CES 2025, the company unveiled this tool designed to analyze users' skin and provide personalized recommendations to delay the signs of aging. This innovative gadget is the result of a collaboration with NanoEntek, a South Korean startup specializing in chips that analyze biofluids.
The operation of the Cell BioPrint begins with the application of an adhesive strip on the cheek, which is then placed in a buffer solution. This mixture is inserted into a cartridge that allows the device to perform its analysis. After processing the sample, the Cell BioPrint takes images of the user's face while they answer a few short questions about skin concerns and aging. L’Oréal claims that it uses proteomics techniques, which involve the study of the structure and function of proteins from a biological sample, to evaluate how the skin is aging. Based on this assessment, the device offers personalized advice to improve skin appearance and makes predictions about the skin's reactivity to certain product ingredients.
Although L’Oréal's proposal sounds promising, the effectiveness of its methods is difficult to verify without peer-reviewed studies or expert opinions. Additionally, the company asserts that the Cell BioPrint can anticipate aesthetic issues before they manifest, such as the tendency toward hyperpigmentation or enlarged pores. This device analyzes skin proteins to determine the user's aging status.
During the COVID-19 lockdowns, skin care gained significant popularity, leading to a trend towards self-care and the rise of "skinfluencers." However, this virulence has pushed skincare product purchases to extreme levels. On platforms like TikTok, it is common to find influencers encouraging spending large amounts of money on products, causing confusion and frustration, as what works for one person may not be effective for another. With the Cell BioPrint, L’Oréal promises to use science to resolve this uncertainty, offering personalized recommendations based on individual biology rather than following general trends.
According to the company, the Cell BioPrint will be easy to use, with a process that takes just five minutes. It will also allow users to repeat tests to monitor changes in their skin over time. However, the launch of this consumer device does not yet have a defined timeline or established price, although L’Oréal mentions that it will begin testing in Asia later this year.
